AU Stock MarketDetailed Quotes

PER Percheron Therapeutics Ltd

Watchlist
  • 0.059
  • -0.004-6.35%
20min DelayMarket Closed Dec 13 16:00 AET
64.16MMarket Cap-4.21P/E (Static)

Percheron Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Percheron Therapeutics Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H11.200M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/H11.200M / 0.000--

Percheron Therapeutics Ltd Earnings Reports

  • Percheron Therapeutics Ltd: Percheron Receives $2.35 million R&D Tax Incentive Rebate

    Oct 7 18:37 ET

  • Percheron Therapeutics Ltd: Appendix 4E and Annual Report

    Aug 29 01:11 ET

  • Percheron Therapeutics Ltd: Half Yearly Report and Accounts

    Feb 28 01:20 ET

    • Trending AU Stocks
    ASX High Dividend ASX High Dividend
    Symbol Mini Chart % Chg
    Westpac Banking Corp
    WBC
    +0.66%
    Woodside Energy Group Ltd
    WDS
    +0.46%
    CommBank
    CBA
    +0.44%
    ANZ Group Holdings Ltd
    ANZ
    +0.03%
    National Australia Bank Ltd
    NAB
    -0.13%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Nov 7, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data